Bank of Nova Scotia (NYSE:BNS) Announces Quarterly Dividend of $0.65

Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) announced a quarterly dividend on Tuesday, May 28th, Zacks reports. Investors of record on Tuesday, July 2nd will be given a dividend of 0.65 per share by the bank on Monday, July 29th. This represents a $2.60 annualized dividend and a yield of 4.88%. The ex-dividend date of this dividend is Friday, June 28th.

Bank of Nova Scotia has increased its dividend by an average of 5.0% per year over the last three years and has increased its dividend annually for the last 2 consecutive years.

BNS traded up $0.33 during trading on Thursday, reaching $53.24. 541,163 shares of the company traded hands, compared to its average volume of 738,886. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $64.73 billion, a P/E ratio of 9.79, a P/E/G ratio of 2.01 and a beta of 1.15. Bank of Nova Scotia has a 12-month low of $48.34 and a 12-month high of $60.60. The business’s fifty day simple moving average is $53.29.

Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) last posted its earnings results on Tuesday, May 28th. The bank reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.04). Bank of Nova Scotia had a net margin of 19.20% and a return on equity of 13.55%. The firm had revenue of $7.80 billion for the quarter, compared to the consensus estimate of $7.60 billion. During the same quarter in the prior year, the company posted $1.70 earnings per share. The firm’s revenue was up 10.6% compared to the same quarter last year. On average, equities research analysts predict that Bank of Nova Scotia will post 5.26 earnings per share for the current year.

BNS has been the topic of several research reports. Zacks Investment Research lowered HEXO from a “hold” rating to a “sell” rating in a research note on Wednesday, May 15th. ValuEngine lowered Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. Finally, Barclays raised Encompass Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $68.00 to $70.00 in a report on Thursday, May 30th. Two analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $77.75.

About Bank of Nova Scotia

The Bank of Nova Scotia provides various banking products and services in North America, Latin America, the Caribbean and Central America, and the Asia-Pacific. The company offers financial advice and solutions, and day-to-day banking products, including debit and credit cards, chequing and saving accounts, investments, mortgages, loans, and related creditor insurance to individuals and small businesses; and commercial banking solutions comprising lending, deposit, cash management, and trade finance solutions to medium and large businesses, including automotive dealers and their customers.

Featured Article: Marijuana Stocks Investing Considerations

Dividend History for Bank of Nova Scotia (NYSE:BNS)

Receive News & Ratings for Bank of Nova Scotia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bank of Nova Scotia and related companies with's FREE daily email newsletter.